Urine cytology: Appropriate usage maximizes sensitivity and reduces cost

Cytopathology

Volumn 16, Issue 3, 2005, Pages 139-142

  Allen, D J ^a,b   Challacombe, B ^a   Clovis, J S ^a   Chandra, A ^a   Dasgupta, P ^a   Popert, R ^a  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^b GUY S HOSPITAL   (United Kingdom)

Author keywords

Audit; Clinical governance; Education; Inappropriate samples; Urine cytology

Indexed keywords

ARTICLE; COST CONTROL; EDUCATION PROGRAM; ELECTRONIC MEDICAL RECORD; FOLLOW UP; HEMATURIA; HUMAN; HUMAN TISSUE; MEDICAL AUDIT; PRIORITY JOURNAL; URINARY TRACT TUMOR; URINE CYTOLOGY;

HEALTH CARE COSTS; HUMANS; SENSITIVITY AND SPECIFICITY; SPECIMEN HANDLING; URINE;

EID: 20444489511     PISSN: 09565507     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2303.2005.00255.x     Document Type: Article

References (12)

1. Lambl WD. Ueber Harnblasenkrebs. Ein Beitrag zur mikroskopichen Diagnostik am Krankenbedtte. Prager Viertelj Sehr Heilkunde 1856;49:1-15.
2. Papanicolaou GN, Marshall VF. Urine sediment smears as a diagnostic procedure in cancers of the urinary tract. Science 1945;101:519-21.
3. Brown FM. Urine cytology. Is it still the gold standard for screening? Ural Clin North Am 2000;27:25-37.
4. Tiguert R, Fradet Y. New diagnostic and prognostic tools in bladder cancer. Curr Opin Urol 2002;12:239-43.
5. Winner HG, Vooijs GP, Van't Hof-Grootenboer B. Accuracy of urinary cytology in the diagnosis of primary and recurrent bladder cancers. Acta Cytol 1993;37:163.
6. Koss LG, Deitch D, Ramanathan R et al. Diagnostic value of cytology of voided urine. Acta Cytol 1985;29:810-4.
7. Bastaky S, Ibrahim S, Wilczynski SP et al. The accuracy of urine cytology in daily practice. Cancer (Cancer Cytopathol) 1984;53:1555-65.
8. Lamm DL. Carcinoma in situ. Urol Clin North Am 1992;19:499-508.
9. Maier U, Simak R, Neuhold N. The clinical value of urinary cytology: 12 years of experience with 615 pts. J Clin Pathol 1995;49:314-7.
10. Del Nero A, Esposito N, Curro A et al. Evaluation of urinary level of NMP22 as a diagnostic marker for pTa-pT1 bladder cancer; comparison with urinary cytology and BTA test. Eur Urol 1999;35:93-7.
11. Ravaler E, Landman J, Chang Y et al. Detecting human bladder cancer cells in voided urine samples by assaying for the presence of telomerase activity. Cancer 1998;82: 708-14.
12. Lokeshwar VB, Obek C, Soloway MS et al. Tumour associated hyaloronic acid: a new sensitive and specific urinary marker for bladder cancer. Cancer Res 1997;57:773-7.